Date | Source | Title | List of Injuries | |
July 14, 2020 | New England Journal of Medicine | An mRNA Vaccine against SARS-CoV-2 – Preliminary Report | Cardiac Disorders, Musculoskeletal and Connective Tissue Disorders, Nervous System Disorders, Respiratory, Thoracic and Mediastinal Disorders, Vascular Disorders, Eye Disorders, Ear and Labyrinth Disorders | |
October 16, 2020 | JAMA | Postapproval Vaccine Safety Surveillance for COVID-19 Vaccines in the US | Anaphylaxis, Guillain-Barré syndrome, Transverse myelitis, myocarditis / pericarditis, Vaccine-associated enhanced respiratory disease, Multisystem inflammatory syndrome in children | |
October 30, 2020 | CDC’s ACIP Committee Meeting | “CDC post-authorization/post-licensure safety monitoring of COVID-19 vaccines” by Tom Shimabukuro, MD, MPH, MBA | Acute disseminated encephalomyelitis (ADEM), Acute myocardial infarction (AMI), Anaphylaxis, Acute respiratory distress syndrome (ARDS), Arthritis and arthralgia / joint pain, Convulsions / seizures, Disseminated intravascular coagulation (DIC), Encephalitis / myelitis / encephalomyelitis / meningoencephalitis / meningitis / encephalopathy (not ADEM or TM), Guillain-Barré syndrome (GBS), Immune thrombocytopenia (ITP), Kawasaki disease (KD), Multisystem Inflammatory Syndrome (MIS-C and MIS-A), Myocarditis / pericarditis, Narcolepsy / cataplexy, Stroke – hemorrhagic and ischemic, Transverse myelitis (TM), Venous thromboembolism (VTE) |